# Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

> **NCT00651976** · EARLY_PHASE1 · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 213 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** letrozole
- **OTHER:** Blood Collection
- **PROCEDURE:** biopsy/lumpectomy/mastectomy

## Key facts

- **NCT ID:** NCT00651976
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-03
- **Primary completion:** 2018-09
- **Final completion:** 2018-09
- **Target enrollment:** 213 (ACTUAL)
- **Why stopped:** funding unavailable
- **Last updated:** 2018-10-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00651976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00651976, "Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00651976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*